Where I see patients (2)
Selected research
-
Impact of Genetic Variants in ABCG2 , NR1I2 , and UGT1A1 on the Pharmacokinetics of Dolutegravir in Children.
Journal of acquired immune deficiency syndromes (1999)
-
Community-Wide Universal Human Immunodeficiency Virus (HIV) Test and Treat Intervention Reduces Tuberculosis Transmission in Rural Uganda: A Cluster-Randomized Trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
-
Population Pharmacokinetic Modeling of Dolutegravir to Optimize Pediatric Dosing in HIV-1-Infected Infants, Children, and Adolescents.
Clinical pharmacokinetics
Contact me
Stress-free visits